Skip to main content

(Approval lapsed) PENOPEN phenoxymethylpenicillin 250mg/5ml powder for oral solution (Cyprus)

Section 19A approved medicine
(Approval lapsed) PENOPEN phenoxymethylpenicillin 250mg/5ml powder for oral solution (Cyprus)
Section 19A approval holder
Pro Pharmaceuticals Group Pty Ltd ABN 20 605 457 431
Phone
1301 077 674
Approved until
Status
Expired
Medicines in short supply/unavailable
PHENOXYMETHYLPENICILLIN-AFT phenoxymethylpenicillin (as potassium salt) 250mg/5ml powder for oral liquid bottle - ARTG 159754
Indication(s)

When oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms such as penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci.

For prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or Sydenham's chorea.

For the prevention of bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation.

Oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or complications of childbirth.

Images
Picture of PENOPEN phenoxymethylpenicillin 250mg/5ml powder for oral solution (Cyprus)

Help us improve the Therapeutic Goods Administration site